Serial Therapeutic and Antifungal Monitoring Protocol
Status: Completed
Location: See all (3) locations...
Study Type: Observational
SUMMARY
The objective of this study is to investigate T2Candida performance as a monitoring tool for post-therapy clearance of Candida compared to blood culture. This study will collect a T2clinical specimen and companion blood culture from patients who have exhibited a positive blood culture by gram stain for yeast, and who are receiving treatment with antifungal therapy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 95
Healthy Volunteers: f
View:
• Subject or subject's authorized representative must be able to understand, read and sign the study specific informed consent form after the nature of the study has been fully explained to them.
• Subject is between 18-95 years of age
• Subject has a blood culture result that is positive for yeast within 36 hours of enrollment
Locations
United States
Alabama
University of Alabama
Birmingham
Pennsylvania
University of Pittsburgh
Pittsburgh
Rhode Island
Rhode Island Hospital
Providence
Time Frame
Start Date: 2014-09
Completion Date: 2017-04
Participants
Target number of participants: 31
Treatments
Candida Positive Patients
Symptomatic adult patients, confirmed via blood culture with species identification to be positive for Candida
Authors
Eleftherios Mylonakis, Peter Pappas, Cornelius Clancy
Related Therapeutic Areas
Sponsors
Leads: T2 Biosystems